Features:Gi-DREADDs signal through the Gαi/o G-protein and inhibit neuronal signalling by inhibiting adenylate cyclase and downstream cAMP production. There are currently two Gi DREADDs based on human muscarinic receptors, hM2Di and hM4Di, and a Gi DREADD based on the human κ-opoid receptor, termed KORD